Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Quantification of clarithromycin polymorphs in presence of tablet excipients

View through CrossRef
Excipients can cause a considerable challenge when developing a solid form of an active pharmaceutical ingredient (API). The aim of this present study was to analyze the polymorphs of clarithromycin (CAM) mixed with excipients using powder X-ray diffraction (PXRD). Polymorphic Form I (CAM-1), Form II (CAM-2) and an amorphous phase of CAM were characterized using thermal and crystallographic methods. CAM-1 and CAM-2 were monotropically related, with CAM-2 being the stable form. PXRD instrument related parameters were optimized for the characterization of CAM polymorphic forms using a variety of excipients. Calibration curves for CAM-1 and CAM-2 mixed with excipients were also prepared. Analytical methods based on the differences in the diffraction patterns of CAM-1, CAM-2 and the excipients were developed. Sodium methyl paraben, sodium propyl paraben, microcrystalline cellulose and magnesium stearate were crystalline showing characteristic diffraction patterns. Starch, croscarmellose sodium, talc and sodium starch glycolate were semicrystalline in nature, while colloidal silicon dioxide was amorphous. A diffraction peak at 8.7° 2θ provided a quantification of CAM-2 when mixed with excipients. The analytical method was evaluated and validated for accuracy, precision, inter- and intra-day variation, variability due to sample repacking and instrument reproducibility. The method for quantification of CAM-2 in the range of 80 to 100% w/w was linear with R2 = 0.998. Relative standard deviation (RSD), due to sample repacking, was 2.77% indicating good homogeneity of mixing of the samples. RSD due to assay errors was 1.66%. PXRD analysis of the commercial tablet showed the CAM-2 as a major polymorph being 98% of the overall content of the API. CAM-1 was found to be present as an impurity at trace levels shown by peaks at 2θ values of 5.2° and 6.7°. This method provides a method for characterization of the polymorphic forms of CAM in the presence of commonly used excipients. It could be a useful tool for monitoring solid form behavior during product development and stability studies.
Title: Quantification of clarithromycin polymorphs in presence of tablet excipients
Description:
Excipients can cause a considerable challenge when developing a solid form of an active pharmaceutical ingredient (API).
The aim of this present study was to analyze the polymorphs of clarithromycin (CAM) mixed with excipients using powder X-ray diffraction (PXRD).
Polymorphic Form I (CAM-1), Form II (CAM-2) and an amorphous phase of CAM were characterized using thermal and crystallographic methods.
CAM-1 and CAM-2 were monotropically related, with CAM-2 being the stable form.
PXRD instrument related parameters were optimized for the characterization of CAM polymorphic forms using a variety of excipients.
Calibration curves for CAM-1 and CAM-2 mixed with excipients were also prepared.
Analytical methods based on the differences in the diffraction patterns of CAM-1, CAM-2 and the excipients were developed.
Sodium methyl paraben, sodium propyl paraben, microcrystalline cellulose and magnesium stearate were crystalline showing characteristic diffraction patterns.
Starch, croscarmellose sodium, talc and sodium starch glycolate were semicrystalline in nature, while colloidal silicon dioxide was amorphous.
A diffraction peak at 8.
7° 2θ provided a quantification of CAM-2 when mixed with excipients.
The analytical method was evaluated and validated for accuracy, precision, inter- and intra-day variation, variability due to sample repacking and instrument reproducibility.
The method for quantification of CAM-2 in the range of 80 to 100% w/w was linear with R2 = 0.
998.
Relative standard deviation (RSD), due to sample repacking, was 2.
77% indicating good homogeneity of mixing of the samples.
RSD due to assay errors was 1.
66%.
PXRD analysis of the commercial tablet showed the CAM-2 as a major polymorph being 98% of the overall content of the API.
CAM-1 was found to be present as an impurity at trace levels shown by peaks at 2θ values of 5.
2° and 6.
7°.
This method provides a method for characterization of the polymorphic forms of CAM in the presence of commonly used excipients.
It could be a useful tool for monitoring solid form behavior during product development and stability studies.

Related Results

Perbandingan Beberapa Bahan Pengisi pada Formulasi Tablet Hisap
Perbandingan Beberapa Bahan Pengisi pada Formulasi Tablet Hisap
Abstrak. Tablet hisap adalah tablet padat yang mengandung satu atau lebih bahan obat. Biasanya tablet hisap ini memiliki rasa dan aroma yang manis sehingga dapat larut perlahan dal...
COPROCESSED EXCIPIENTS-PREPARATION AND FUNCTIONALITIES
COPROCESSED EXCIPIENTS-PREPARATION AND FUNCTIONALITIES
With the advancements of tablet manufacturing techniques, the urge to develop and produce high, multifunctional excipients have been increased to meet the set of functionalities. T...
Bahan Tambahan dalam Sediaan Tablet: Review
Bahan Tambahan dalam Sediaan Tablet: Review
Tablets are solid pharmaceutical dosage form without or with suitable excipients by press or compression manufacturing process. The excipient chosen can influence the product perfo...
Method Development of Clarithromycin by Chromophore Addition through Chemical Derivatization
Method Development of Clarithromycin by Chromophore Addition through Chemical Derivatization
Introduction: Clarithromycin is a macrolide antibiotic that is active against a variety of microorganisms. It is widely used in the local and international market in different pha...
Preparation and Characterization of Hydrophilic Polymer Based Sustained-Release Matrix Tablets of a High Dose Hydrophobic Drug
Preparation and Characterization of Hydrophilic Polymer Based Sustained-Release Matrix Tablets of a High Dose Hydrophobic Drug
The objective of this study was the preparation and characterization of a sustained-release matrix tablet containing a high-dose hydrophobic drug and its comparison with marketed p...
Excipients Used in Pediatric Oral Dosage Forms: Challenges and Perspectives for Safe Hospital Practice
Excipients Used in Pediatric Oral Dosage Forms: Challenges and Perspectives for Safe Hospital Practice
The pharmacological management of pediatric patients remains a major challenge, particularly in low-resource settings. Oral dosage forms, widely used in children, require appropria...
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Abstract Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithrom...
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Abstract Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We ...

Back to Top